Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TMS effects on eye structures in depression
NCT06615804Completed
- Sponsor
- Gulhane Training and Research Hospital
- Start
- Dec 2022
- Primary completion
- May 2023
- Countries
- 1
01
Overview
Open-label trial (2 arms), sponsored by Gulhane Training and Research Hospital. Primary endpoints: Retinal Nerve Fiber Layer Thickness at 4 weeks, Macula Thickness at 4 weeks and 1 more. Started Dec 2022; status: completed.
Beyond the preview
Go deeper on NCT06615804.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06615804.